A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
- Conditions
- COVID-19 Pneumonia
- Interventions
- Registration Number
- NCT04409262
- Lead Sponsor
- Hoffmann-La Roche
- Brief Summary
This study will evaluate the efficacy and safety of combination therapy with remdesivir plus tocilizumab compared with remdesivir plus placebo in hospitalized patients with COVID-19 pneumonia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 649
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Remdesivir + Tocilizumab (RDV+TCZ) Remdesivir Participants assigned to the RDV+TCZ arm will receive a 10-day treatment course of RDV, plus one infusion of TCZ on Day 1. Remdesivir + Placebo (RDV+Placebo) Placebo Participants assigned to the RDV+ placebo arm will receive a 10-day treatment course of RDV, plus one infusion of TCZ-placebo on Day 1. Remdesivir + Tocilizumab (RDV+TCZ) Tocilizumab Participants assigned to the RDV+TCZ arm will receive a 10-day treatment course of RDV, plus one infusion of TCZ on Day 1. Remdesivir + Placebo (RDV+Placebo) Remdesivir Participants assigned to the RDV+ placebo arm will receive a 10-day treatment course of RDV, plus one infusion of TCZ-placebo on Day 1.
- Primary Outcome Measures
Name Time Method Time to Hospital Discharge or "Ready for Discharge" up to Day 28 Up to Day 28 Defined as days from randomization to hospital discharge or "Ready for Discharge" not followed by ordinal scale category \>1, hospital readmission or death. Hospital discharge or "Ready for Discharge" is defined as an ordinal score of 1 on the 7-point ordinal scale. Participants who die are censored at Day 28.
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. Death
- Secondary Outcome Measures
Name Time Method Time to Mechanical Ventilation or Death up to Day 28 Up to Day 28 Time to Mechanical Ventilation or Death defined as the time from randomization to the first occurrence of death or mechanical ventilation. For participants already on mechanical ventilation at baseline, only death is counted as an event.
Time to Death up to Day 60 Up to Day 60 Time to death is defined as the time from randomization to death.
Clinical Status as Assessed by the Investigator Using a 7-category Ordinal Scale of Clinical Status on Day 7 Day 7 Clinical status was assessed by the investigator according to the following ordinal scale categories:
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathClinical Status as Assessed by the Investigator Using a 7-category Ordinal Scale of Clinical Status on Day 21 Day 21 Clinical status was assessed by the investigator according to the following ordinal scale categories:
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathProportion of Participants Who Are Alive and Free of Respiratory Failure at Day 28 and Day 60 (Participants Requiring Mechanical Ventilation at Baseline) Day 28 and Day 60 Difference in Mortality at Days 14, 28, and 60 Days 14, 28, and 60 Time to Recovery up to Day 28 Up to Day 28 Defined as the time from randomization to the time when an ordinal scale category of 2 (non-ICU hospital ward or "ready for hospital ward" not requiring supplemental oxygen) or better is observed, not followed by ordinal scale category \>2 or death. Participants who die are censored at day 28.
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathProportion of Participants Who Are Discharged or "Ready for Discharge" up to Day 28 Up to Day 28 Defined as hospital discharge or "Ready for Discharge" not followed by ordinal scale category \>1, hospital readmission or death.
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathProportion of Participants Who Require Initiation of Mechanical Ventilation Post-baseline or Die up to Day 28 Up to Day 28 Participants already on mechanical ventilation at baseline are only counted as an event if death occurs.
Clinical Status as Assessed by the Investigator Using a 7-category Ordinal Scale of Clinical Status on Day 14 Day 14 Clinical status was assessed by the investigator according to the following ordinal scale categories:
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathTime to Death up to Day 28 Up to Day 28 Time to death is defined as the time from randomization to death.
Time to Improvement of at Least 2 Categories Relative to Baseline on a 7-category Ordinal Scale of Clinical Status up to Day 28 Up to Day 28 Defined as time from randomization to the time when at least a 2-category improvement in the 7-category ordinal scale is observed. Patients who die are censored at day 28.
Clinical status was assessed by the investigator according to the following ordinal scale categories:
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathClinical Status as Assessed by the Investigator Using a 7-category Ordinal Scale of Clinical Status on Day 28 Day 28 Clinical status was assessed by the investigator according to the following ordinal scale categories:
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathClinical Status as Assessed by the Investigator Using a 7-category Ordinal Scale of Clinical Status on Day 60 Day 60 Clinical status was assessed by the investigator according to the following ordinal scale categories:
1. Discharged (or "ready for discharge" as evidenced by normal temperature and respiratory rate, and stable oxygen saturation on ambient air or \</= 2L supplemental oxygen)
2. Non-intensive care unit (ICU) hospital ward (or "ready for hospital ward") not requiring supplemental oxygen
3. Non-ICU hospital ward (or "ready for hospital ward") requiring supplemental oxygen
4. ICU or non-ICU hospital ward, requiring non-invasive ventilation or high-flow oxygen
5. ICU, requiring intubation and mechanical ventilation
6. ICU, requiring extracorporeal membrane oxygenation (ECMO) or mechanical ventilation and additional organ support (e.g., vasopressors, renal replacement therapy)
7. DeathProportion of Participants Requiring Initiation of Mechanical Ventilation Post-baseline (Participants Who Did Not Require Mechanical Ventilation at Baseline) Day 28 and Day 60 Day 28: Participants who withdraw or die prior to Day 28 are assumed to have required mechanical ventilation. Participants without mechanical ventilation prior to discharge are assumed not to have required mechanical ventilation unless they die by Day 28, which are counted as an event.
Day 60: Participants who withdraw or die prior to Day 60 are assumed to have required mechanical ventilation. Participants without mechanical ventilation prior to discharge are assumed not to have required mechanical ventilation unless they die by Day 60, which are counted as an event.Duration of Mechanical Ventilation (Participants Requiring Mechanical Ventilation at Baseline) up to Day 28 Up to Day 28 Participants who die by Day 28 are assigned a duration of 28 days.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (54)
Valleywise Health Medical Center
🇺🇸Phoenix, Arizona, United States
eStudySite - Chula Vista - PPDS
🇺🇸Chula Vista, California, United States
Hoag Hospital Irvine
🇺🇸Irvine, California, United States
Providence St Johns Health Center
🇺🇸Santa Monica, California, United States
Yale University School of Medicine; HIV Clinical Trials Program
🇺🇸New Haven, Connecticut, United States
Medstar Georgetown University Hospital
🇺🇸Washington, District of Columbia, United States
Holy Cross Hospital Inc
🇺🇸Fort Lauderdale, Florida, United States
Larkin Community Hospital Palm Springs Campus (Hialeah)
🇺🇸Hialeah, Florida, United States
University of Miami Miller School of Medicine; Clinical Reseach Building
🇺🇸Miami, Florida, United States
Larkin Community Hospital
🇺🇸South Miami, Florida, United States
Scroll for more (44 remaining)Valleywise Health Medical Center🇺🇸Phoenix, Arizona, United States